Functionalized Indole and Quinoline Derivatives
J . Org. Chem., Vol. 67, No. 10, 2002 3433
382 (16), 324 (100), 137 (56); HRMS (EI) calcd for C21H35NO6Si
425.2233, found 425.2229.
mediately became darker. After 30 min, the ice bath was
removed, and the reaction was stirred at room temperature
for 1 h. Progression of the reaction was monitored by the
disappearance of the orthoquinol acetate, as indicated by TLC
[hexanes/Et2O (1:1) and then CH2Cl2/MeOH (20:1)]. The
mixture was diluted with EtOAc (30 mL), poured into ice-cold
water (10 mL), extracted with EtOAc (2 × 15 mL), washed
with brine (2 × 10 mL), dried over Na2SO4, filtered, and
evaporated at room temperature. The resulting dark oily
residue was purified by column chromatography, eluting with
CH2Cl2/MeOH (100:1), to afford 10b as an orange oil (26 mg,
N-Tsoc-6-a cetoxy-4-(3-a m in op r op yl)-6-m eth oxycyclo-
h exa -2,4-d ien on e (9b ). Bright yellow oil (98%). IR (NaCl)
3372, 1750, 1702, 1681 cm-1 1H NMR (CDCl3, 200 MHz) δ
;
1.06 (d, J ) 6.7 Hz, 18H), 1.24 (h, J ) 6.9 Hz, 3H), 1.65-1.79
(m, 2H), 2.09 (s, 3H), 2.28 (bt, J ) 7.6 Hz, 2H), 3.05-3.26 (m,
2H), 3.44 (s, 3H), 4.91 (bs, 1H), 5.93 (d, J ) 2.1 Hz, 1H), 6.11
(d, J ) 10.2 Hz, 1H), 6.77 (dd, J ) 2.1, 10.2 Hz, 1H); 13C NMR
(CDCl3, 62.9 MHz) δ 191.5, 169.5, 155.0, 142.1, 137.7, 129.3,
125.8, 92.9, 51.1, 40.1, 29.6, 22.6, 20.4, 17.7, 11.9; LSIMS m/z
(rel intensity) 462 (MNa+, 29), 438 (14), 396 (13), 380 (19).
6-Acetoxy-6-m eth oxy-4-(2-m eth oxyca r bon yla m in o-eth -
yl)-cycloh exa -2,4-d ien on e (9c). Orange oil (92%). A 3:2
mixture of 9c and 9f was obtained after 1 day, and degradation
58%): IR (NaCl) 3406 cm-1 1H NMR (CDCl3, 200 MHz) δ
;
1.86-1.98 (m, 2H), 2.68 (bt, J ) 6.3 Hz, 2H), 3.21-3.26 (m,
2H), 3.79 (s, 3H), 4.28 (bs, 2H), 6.19 (s, 1H), 6.50 (s, 1H); 13C
NMR (CDCl3, 50 MHz) δ 144.6, 139.3, 138.4, 112.9, 101.9, 56.8,
42.1, 26.4, 22.5; LSIMS m/z (rel intensity) 180 (MH+, 54), 179
(M+, 100), 178 (41), 164 (26); HRMS (LSIMS) calcd for
was further observed. IR (NaCl) 3372, 1750, 1692, 1676 cm-1
;
1H NMR (CDCl3, 250 MHz) δ 1.96 (s, 3H), 2.02 (s, 3H), 2.35
(bt, J ) 6.4 Hz, 4H), 3.05-3.22 (m, 4H), 3.36 (s, 3H), 3.37 (s,
3H), 3.55 (s, 3H), 3.59 (s, 3H), 5.06 (bs, 1H), 5.16 (bs, 1H), 5.73
(d, J ) 2.4 Hz, 1H), 5.89 (s, 1H), 6.05 (d, J ) 10.1 Hz, 1H),
6.20 (d, J ) 10.1 Hz, 1H), 6.72 (dd, J ) 1.8, 10.1 Hz, 1H), 6.83
(dd, J ) 2.4, 10.3 Hz, 1H); 13C NMR (CDCl3, 62.9 MHz) δ 191.4,
180.2, 169.7, 169.1, 156.8, 156.7, 151.1, 148.2, 141.9, 135.4,
130.7, 127.7, 126.0, 113.9, 92.7, 77.3, 54.8, 51.8, 51.2, 39.9, 38.6,
36.1, 35.0, 21.3, 20.3; LSIMS m/z (rel intensity) 306 (MNa+,
100), 284 (MH+, 9), 268 (6), 252 (10), 224 (27).
C
10H13NO2 179.0946, found 179.0945.
N-Met h oxyca r b on yl-6-h yd r oxy-5-m et h oxy-2,3-d ih y-
d r oin d ole (10c). To a stirred solution of 9c (100 mg, 0.35
mmol) in dry THF (5 mL) cooled at -8 °C was added dropwise
a commercial solution of LHMDS (1.0 M in THF, 2.0 equiv).
After stirring for 1 h at -8 °C, the mixture was allowed to
warm to room temperature for 30 min, and was then diluted
with EtOAc (30 mL) and water (10 mL). After separation, the
aqueous phase was extracted with EtOAc (20 mL), and the
organic phase was washed with brine (10 mL), dried over
Na2SO4, filtered, and evaporated to furnish a dark oily residue,
which was purified by column chromatography, eluting with
CH2Cl2/MeOH (40:1), to afford 10c as amber crystals (25.2 mg,
6-Acetoxy-4-ben zylca r ba m oylm eth yl-6-m eth oxycyclo-
h exa -2,4-d ien on e (9d ). Bright yellow oil (95%). IR (NaCl)
3318, 1745, 1671, 1652 cm-1 1H NMR (CDCl3, 200 MHz) δ
;
1.98 (s, 3H), 3.16 (d, J ) 3.7 Hz, 2H), 3.42 (s, 3H), 4.25 (dd, J
) 5.5, 14.6 Hz, 1H), 4.42 (dd, J ) 6.3, 14.6 Hz, 1H), 6.08 (bs,
1H), 6.10 (d, J ) 9.8 Hz, 1H), 6.70 (bs, 1H), 6.77 (dd, J ) 2.2,
9.8 Hz, 1H), 7.16-7.31 (m, 5H); 13C NMR (CDCl3, 50.3 MHz)
δ 191.0, 170.2, 168,4, 141.8, 137.9, 133.0, 132.5, 128.3, 127.6,
127.2, 126.4, 92.7, 51.3, 43.4, 42.3, 20.3. Evolution of ortho-
quinol acetate 9d in the NMR tube (CDCl3 as solvent) at room
1
32%): mp 153-155 °C; IR (KBr) 3322, 1695 cm-1; H NMR
(CDCl3, 200 MHz) δ 3.02 (bt, J ) 8.6 Hz, 2H), 3.83 (s, 6H),
3.88-4.06 (m, 2H), 5.75 (bs, 1H), 6.69 (s, 1H), 7.26 (s, 1H); 13
C
NMR (CDCl3, 50 MHz) δ 144.9, 142.3, 121.3, 114.4, 111.2,
107.9, 102.7, 56.5, 52.5, 47.8, 27.8; EIMS m/z (rel intensity)
225 (8), 224 (MH+, 42), 223 (M+, 100), 208 (17); HRMS (LSIMS)
calcd for C11H13NO4 223.0844, found 223.0845.
1
temperature was monitored by H NMR. A 1:1 mixture of 9d
and 9g was obtained after 3 days, and degradation was further
observed. 1H NMR (CDCl3, 200 MHz) δ 1.87 (s, 3H), 194 (s,
3H), 2.69 (s, 2H), 3.12 (d, J ) 3.3 Hz, 2H), 3.37 (s, 3H), 3.51
(s, 3H), 3.62-3.78 (m, 2H), 4.34 (d, J ) 5.9 Hz, 2H), 5.99 (d, J
) 2.7 Hz, 1H), 6.03-6.08 (m, 1H), 6.14 (d, J ) 10.0 Hz, 1H),
6.73 (dd, J ) 2.1, 10.0 Hz, 1H), 6.86 (bs, 2H), 7.05 (dd, J )
2.7, 10.1 Hz, 1H), 7.16-7.29 (m, 11H); 13C NMR (CDCl3, 50
MHz) δ 191.1, 180.3, 173.9, 170.2, 169.3, 168.7, 166.9, 150.7,
147.6, 141.8, 137.9, 137.7, 132.9, 132.4, 128.4, 128.3, 127.4,
127.3, 127.2, 127.1, 126.2, 113.8, 92.7, 76.2, 54.8, 51.3, 46.2,
43.3, 42.1, 21.2, 20.5, 20.3.
N-Ben zyl-6-h yd r oxy-5-m eth oxy-2-oxin d ole (10d ). To a
stirred solution of 9d (75 mg, 0.23 mmol) in dry THF (10 mL)
was added KOt-Bu (28 mg, 0.25 mmol) in one portion. After
refluxing overnight, the reaction mixture was diluted with
EtOAc (50 mL) and water (15 mL); the aqueous phase was
extracted with EtOAc (2 × 20 mL). The combined extracts were
washed with brine (15 mL), dried over Na2SO4, filtered, and
evaporated to afford 26 mg of crude product. Purification by
column chromatography, eluting with CH2Cl2/MeOH (50:1),
furnished 10d as a dark oil (10.6 mg, 17%): IR (NaCl) 3376,
1664 cm-1; 1H NMR (acetone-d6, 200 MHz) δ 3.49 (s, 2H), 3.83
(s, 3H), 4.41 (d, J ) 6.1 Hz, 2H), 6.78 (s, 1H), 6.79 (s, 1H),
7.25-7.35 (m, 5H), 7.49 (s, 1H); 13C NMR (acetone-d6, 50 MHz)
δ 173.7, 146.9, 144.8, 138.2, 128.6, 127.5, 126.5, 122.3, 114.8,
111.7, 55.9, 43.5, 29.7; LSIMS m/z (rel intensity) 292 (MNa+,
5), 272 (100), 271 (54), 270 (MH+, 9), 269 (M+, 5), 254 (5).
N-Ben zyl-7-h yd r oxy-6-m eth oxy-3,4-d ih yd r o-2-oxoqu i-
n olin e (10e). To a stirred solution of 9e (50 mg, 0.146 mmol)
in dry THF (10 mL) was added KOt-Bu (18 mg, 0.160 mmol)
in one portion. After refluxing overnight, the reaction mixture
was diluted with EtOAc (50 mL) and water (15 mL); the
aqueous phase was extracted with EtOAc (2 × 20 mL). The
combined extracts were washed with brine (15 mL), dried over
Na2SO4, filtered, and evaporated to afford a pale orange oily
crude product. Purification by column chromatography, eluting
with CH2Cl2/MeOH (50:1), furnished 10e as an off-white solid
(16 mg, 38%): mp 134-135 °C; IR (KBr) 3404, 1658 cm-1; 1H
NMR (CDCl3, 250 MHz) δ 2.72-2.79 (m, 2H), 2.86-2.94 (m,
2H), 3.85 (s, 3H), 5.12 (s, 2H), 6.55 (s, 1H), 6.67 (s, 1H), 7.19-
7.35 (m, 5H); 13C NMR (CDCl3, 62.9 MHz) δ 170.3, 144.6, 142.0,
136.9, 133.7, 128.7, 127.0, 126.4, 117.5, 110.8, 103.6, 56.3, 46.2,
32.2, 25.2; LSIMS m/z (rel intensity) 306 (MNa+, 45), 285 (31),
284 (MH+, 75), 283 (M+, 100), 268 (22), 252 (29); HRMS
(LSIMS) calcd for C17H17NO3 283.1208, found 283.1210.
5-(Tr ieth ylsilyloxym eth yl)-6-iodo-1,3-ben zodioxole (27).
To a stirred ice-cold suspension of 5-(hydroxymethyl)-6-iodo-
1,3-benzodioxole 2556 (3.00 g, 10.8 mmol) in dry CH2Cl2 (55
mL) were added dropwise Et3N (1.8 mL, 12.9 mmol) and TES-
6-Ace t oxy-4-(2-b e n zylca r b a m oyl-e t h yl)-6-m e t h oxy-
cycloh exa -2,4-d ien on e (9e). Bright yellow oil (99%). IR
(NaCl) 3338, 1750, 1674, 1651 cm-1 1H NMR (CDCl3, 200
;
MHz) δ 2.00 (s, 3H), 2.29-2.37 (m, 2H), 2.50-2.57 (m, 2H),
3.38 (s, 3H), 4.33 (d, J ) 5.9 Hz, 2H), 5.95 (d, J ) 2.0 Hz, 1H),
6.00 (d, J ) 10.0 Hz, 1H), 6.45 (bs, 1H), 6.70 (d, J ) 2.0, 10.0
Hz, 1H), 7.18-7.32 (m, 5H); 13C NMR (CDCl3, 50.3 MHz) δ
191.5, 171.1, 169.5, 142.3, 138.0, 137.4, 129.6, 128.4, 127.5,
127.2, 125.7, 92.9, 51.2, 43.3, 34.9, 30.6, 20.3. Evolution of
orthoquinol acetate 9e in the NMR tube (CDCl3 as solvent) at
room temperature was monitored by 1H NMR. The conversion
to the 4-acetoxy-4-(2-benzylcarbamoyl-ethyl)-2-methoxycyclo-
hexa-2,5-dienone 9h was complete after 3 days. Evaporation
of the solvent afforded an orange oil: IR (NaCl) 3368, 1758
cm-1 1H NMR (CDCl3, 200 MHz) δ 1.99 (s, 3H), 2.09-2.37
;
(m, 2H), 2.45 (bt, J ) 7.4 Hz, 1H), 2.84 (bt, J ) 7.4 Hz, 1H),
3.54 (s, 3H), 4.31 (bt, J ) 5.9 Hz, 2H), 5.67 (d, J ) 2.6 Hz,
1H), 6.15 (d, J ) 10.2 Hz, 1H), 6.64 (bs, 1H), 6.75 (d, J ) 2.6,
10.2 Hz, 1H), 7.04-7.31 (m, 5H); 13C NMR (CDCl3, 50.3 MHz)
δ 180.6, 171.4, 169.2, 151.2, 137.8, 128.4, 128.3, 127.9, 127.5,
127.3, 127.2, 114.3, 78.2, 54.7, 43.4, 34.2, 29.8, 20.6; EIMS m/z
(rel intensity) 343 (M+, 0.5), 285 (99),283 (8),150 (62), 137 (52),
91 (100).
7-Hydr oxy-6-m eth oxy-1,2,3,4-tetr ah ydr oqu in olin e (10b).
To a stirred ice-cold solution of 9b (110 mg, 0.25 mmol) in dry
THF (5 mL) was added dropwise a commercial solution of
TBAF (1 M in THF, 1.1 equiv). The reaction mixture im-